Please select the option that best describes you:

How would you manage axial spondyloarthritis in a patient who was doing well on TNF inhibitor therapy then developed a new solid organ malignancy while on treatment?  

How does the management differ if the cancer is resectable or requires systemic treatment?



Answer from: at Academic Institution
Sign in or Register to read more